bendamustine hydrochloride has been researched along with Colicky Pain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gurung, R; Robertson, C; Vickers, MA | 1 |
| Madhyastha, SP; Sharma, S; Singh, A; Udupa, K | 1 |
| Atmar, J; Mullen, E | 1 |
1 review(s) available for bendamustine hydrochloride and Colicky Pain
| Article | Year |
|---|---|
Norovirus in immunocompromised patients.
Topics: Abdominal Pain; Aged; Antibodies, Monoclonal, Murine-Derived; Antidiarrheals; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Caliciviridae Infections; Combined Modality Therapy; Disinfection; Female; Fluid Therapy; Gastroenteritis; Hand Disinfection; Humans; Immunocompromised Host; Incidence; Infection Control; Lymphoma, Follicular; Mitoxantrone; Nitrogen Mustard Compounds; Norovirus; Rituximab; Virus Shedding | 2013 |
2 other study(ies) available for bendamustine hydrochloride and Colicky Pain
| Article | Year |
|---|---|
Paraprotein associated syndrome treated successfully with chemotherapy.
Topics: Abdominal Pain; Antineoplastic Agents; Bendamustine Hydrochloride; Diagnosis, Differential; Erythema Nodosum; Female; Humans; Immunoglobulin M; Lymphocytosis; Middle Aged; Paraproteins; Patient Care Management; Rituximab; Schnitzler Syndrome; Treatment Outcome; Weight Loss | 2020 |
Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen.
Topics: Abdominal Pain; Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Diagnosis, Differential; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Rituximab; Vomiting | 2018 |